Notice of Applicant Information Webinar and Frequently Asked Questions (FAQ) for NHGRI IGNITE II RFAs: RFA-HG-17-008, RFA-HG-17-009 and RFA-HG-17-010

Notice Number: NOT-HG-17-014

Key Dates
Release Date: August 9, 2017

Related Announcements

Issued by
National Human Genome Research Institute (NHGRI)


This Notice is to inform potential applicants to RFA-HG-17-008, RFA-HG-17-009, and RFA-HG-17-010 of a pre-application webinar and frequently asked questions (FAQs).


The intent of the webinar is to provide an overview of the initiatives and to answer questions from potential applicants pertinent to preparing applications. The webinar is optional (attendance is not required for application submission), and the webinar may conclude before the scheduled time depending on the number of questions.

Webinar Information: 
Date: Thursday, August 17, 2017
Time: 1:00 – 3:00 PM EDT

NHGRI staff will post information about how to participate in the Webinar (including conference call information) at  Prospective applicants are encouraged to submit their questions or comments regarding the RFAs to before August 17, 2017. Please indicate “IGNITE II RFA Pre-Application Webinar” in the subject line of your email.

The email message should contain:
Email address
Plans to join by internet or by phone. 

NHGRI staff will post information about how to participate in the Webinar at Prospective applicants may ask additional questions during the Webinar, and NHGRI staff will respond to those questions. Following the Webinar, NHGRI will post slides from the webinar at the same URL.


As a result of discussions with potential applicants to the IGNITE II FOAs, NHGRI has generated a document of Frequently Asked Questions (FAQs) and answers ( These FAQs will be updated with a summary of questions and answers from the webinar and may be updated with additional questions and answers without additional notice.

Prospective applicants with inquiries concerning the FOA are encouraged to view the FAQs. Prospective applicants are strongly encouraged to contact NHGRI to discuss their proposed trial and patient population as well as any questions that were not addressed in the FAQs. Please contact the Scientific/Research contacts listed under Inquiries.


Please direct all inquiries to:

Ebony Madden, Ph.D.
National Human Genome Research Institute
Telephone: 301-503-5620